All Type of News
Bayer Schering Pharma to expand contraceptive market share
Bayer Schering Pharma is gearing up to expand its presence in the domestic contraceptive market by launching a new low-dose oral contraceptive called Yasmin in October, together with Postinor-1, an emergent oral contr...
Over 600 BW level of outpatient prescriptions issued in June.
A monthly 600 billion won of the prescription issuance for outpatients was repeated again in June this year following the end of last year, showing ever rising trend of the prescription drug markets as well as a remar...
Korea and EucoMed consider an industrial exchange program.
Korea and EU have moved an exchange program for the medical device and equipment industries.
Secretary general Maurice Wagner of EucoMed and the chief commissioner and Ms. Choi Eun-jin of EU chambers of commerce i...
Lip care market heats up
This year's lip care market is expected to become fierce between foreign and domestic makers, stepping up more aggressive marketing campaigns towards pharmacies with a variety of massive incentives and gift offerings....
Five-day workweek stirs debate among wholesalers
200 wholesalers in Seoul decided to forcibly adopt the five-day workweek system from this month, in a bid to reduce the workload for wholesalers' employees.
However, Kim Chung-soo, an auditor of the Korea Pharmaceu...
Hwail targets aggressive expansion
Hwail Pharm, a local pharmaceutical bulk manufacturer, has pledged an aggressive expansion strategy in functional food market.
Hwail posted net income of 4.5 billion won in 2006 with its gross sales of 54.9 billion...
Female pharmacists stand out since 1990
As more women participate in economic activities amid rising education levels, the number of female pharmacists has increased at a rapid pace since 1990.
According to the Korea Pharmaceutical Association (KPA), the...
Korea top brand of liver protective drug, Ursa, raised its price.
Taking effect from the coming August, the unit price of Ursa PTP packs will be increased by 10%. Ursa has been known as one of the top brand drugs for the protection of liver.
According to the pharmaceutical dist...
Kyungdong's Reductil modified new drug to be soon approved.
Kyungdong pharmaceutical company announced on July 13 that a modified drug of sibutramine (Reductil), an anti-obesity drug, called Silumin capsule would be approved by the KFDA shortly around the coming Oct.
Kyungd...
Novartis's Zelmac to be released soon
Zelmac, a drug used to treat irritable bowel syndrome, will be on the market shortly, according to Novartis Korea.
Sales of the drug have been temporarily halted from April owing its link to an increased risk of he...
